Abstract: Folate plays one of the most important functions for nucleotide biosynthesis and cellular methylation reactions in cells. Folate-mediated one-carbon metabolism is essential for metabolic processes in the human body. During periods of rapid cell growth, such as perinatal period, increased amounts of folate are required. The determination of red blood cell (RBC) folate concentration levels is the most accurate indicator of long-term folate level status in the body. This prospective study determined RBC folate concentration levels on the first day of life from umbilical cord blood samples in the whole group of full-term newborns (n = 150), who were hospitalized at the Department of Neonatology at the University Hospital in Bratislava. Immunochemical analysis for the determination of folate levels in erythrocytes was performed (Roche Diagnostics, Germany). Mothers were asked to select different types of food and use folic acid or other multivitamin supplements containing also folic acid. Our results of RBC folate ranged from 625 to 1748 ng/mL (5 th -95 th percentile). The median was 935 ng/mL and deficiency was not observed in any sample. RBC folate concentration levels in newborns due to mother's intake of multivitamin supplements were significantly increased (p = 0.02). No differences were observed in the levels of RBC folate concentration when mothers used only folic acid. The RBC folate concentration tended to change based on many factors on both the mother's and the newborn's sides. Our results showed different results of RBC folate when focused on neonatal period and maternal intake of vitamins during pregnancy.
Introduction
At the beginning of the 20 th century it was originally discovered that yeast extract contained a factor which participated in megaloblastic anaemia in pregnancy. It was isolated in 1941 from spinach and received its name (folium, i.e. leaf). Folic acid is composed of a pteridine ring, p-aminobenzoic acid and glutamic acid (Hoffbrand & Weir 2001) . It is a synthetic form of folate used in nutritional supplements or food fortification. Folate exists in many structural forms occurring naturally and as a synthetic one known as vitamin B 9 (Jackson 2006) .
The 5-methyl-tetrahydrofolate (5-MTHF) is the dominant folate form in the serum. It is presented either free, bound to a high-affinity folate-binding protein, or loosely associated with other serum proteins including albumin (Matherly & Goldman 2003) . The 5-MTHF is formed from 5.10-metyltetrahydrofolate (5.10-MTHF) in the reaction catalysed by methylentetrahydrofolate reductase (MTHFR). This reaction is required for the conversion of homocysteine to methionine. The 5.10-MTHF is used for thymidine synthesis (van der Linden et al. 2006) . Other enzymes participate in folate metabolism, among them phosphoribosyl glycinamide transformylase, which is a protein required for purine synthesis. Folate-mediated carbon metabolism is essential for metabolic processes in the body (Beaudin & Stover 2007) . For healthy embryonic growth the optimal folate status in cells is needed to secure optimal DNA methylation status. It is also known that the aging process by itself is accompanied by alterations in DNA methylation. Age and reduced folate intake can alter folate metabolism (Kim et al. 2009 ). Interference of abnormal metabolism in the pathogenesis of neural tube defects (NTD) and neurological and vascular diseases have been elucidated (Hoffbrand & Weir 2001; Behunova et al. 2010) . Some epigenetic factors of dietary folate have also been published with regard to the development of asthma. Folate supplementation during pregnancy can lead to preventing allergic diseases in childhood. To follow up these notions, further studies are required (Peroni et al. 2012) . Also a link between polymorphisms in the folate metabolic pathway and a risk for Down syndrome pregnancy, indicating complex gene-gene interactions were suggested (Coppede et al. 2010) .
Currently the importance of some nutrients during the critical stages of pregnancy is recognized. The exposure to epigenetic changes is responsible for altering the mechanisms of growth and metabolism and leads to changes that may persist throughout life causing increased susceptibility to disease. Some factors before and after birth can decrease levels of stress and mental illness (Capra et al. 2013) .
The requirement of periconceptual supplementation with folate was documented repeatedly. Risk factors associated with birth defects of central nervous system include deficiency of folate supplementation, cigarette smoking and exposure to X-rays (Raza et al. 2012) . In developing countries, folic acid and iron supplementation of pregnant women could be beneficial to prevent children's malnutrition. Early childhood stunting predicts poor human capital including decreased offspring birth weight and shorter adult height (Sachdev 2012) . The influence of folic acid during pregnancy on the birth weight and risk of intrauterine growth retardation were observed in some studies (Rondo & Tomkins 2000; Relton et al. 2005) . Folic acid participates in cardiovascular prevention, too (Guardamagna et al. 2012) . It is also a part of a comprehensive lipid-lowering therapy. The administration of folic acid (10 mg daily) could modify the fibrate-induced elevation of plasma homocysteine and cysteine levels (Melenovsky et al. 2003) .
The red blood cell (RBC) folate is the primary indicator determining a folate adequacy. Because folate is taken up only by the developing erythrocytes in the bone marrow and not by the circulating mature erythrocytes during their 120-day lifespan, erythrocyte folate concentration is an indicator of long-term status (Institute of Medicine, Food and Nutrition Board 1998). Plasma folate concentration decreases markedly with age (van Beynum et al. 2005) . The normal range of RBC folate values vary due to the different analytical methods used to assess the RBC folate concentrations (Jackson 2006) . Folate intake data vary due to the lack of differentiation between naturally occurring folates and synthetic folic acid and the diversity of analytical methods for quantifying folate and folic acid in food (Bouckaert et al. 2011) . Most surveys define reference intake of folate in children older than 6 months. The Nordic countries set the reference intake to 50 µg per day (Becker et al. 2004) , which was based on findings associated with healthy children under the age of 2. These findings indicate that a level of dietary intake of 3.6-5 µg/kg of body weight is adequate for the maintenance of healthy infants (Asfour et al. 1977) . The Germanspeaking countries set the adequate intake of 85 µg/day for infants aged 4-12 months, whereas for children up to 4 months of age (assuming that breast milk provides 12 µg/100 kcal) the dosage of 60 µg per day is recommended (D-A-CH 2013) . To determine what the optimal intake of folate in newborns is, it is important to diagnose the real concentration of folate levels on the first day of life. The useful fact is also to know the state of folate intake during pregnancy. These facts led to the realization of the present study.
Material and methods
The study included newborns (n = 150) hospitalized at the Department of Neonatology in the University Hospital in Bratislava between the years 2010 and 2012. Blood samples from umbilical cord were collected on the first day of life. Full-term healthy newborns who were delivered spontaneously or by Cesarean delivery at gestational age ≥ 38 weeks (birth weight 3350 ± 750 grams) were included in this study. All newborns with the haemolytic disease of the newborns, multiple congenital anomalies and severe bleeding (blood losses more than 2 g/dL for 24 hours) were excluded.
Blood samples for determining RBC folate were collected in vacutainers containing ethylenediaminetetraacetic acid and taken to the Department of Clinical Biochemistry in the Children's University Hospital in Bratislava. Within 24 hours of collection full blood count analysis (especially haematocrit) was executed. Remaining blood was stored at -20
• C for up to one month according to the specifications of the producer's sets and in line with the literature data (Zemlin et al. 2010) . The blood samples were defrosted and processed within one month. The lysing agent (1.5 mL 0.2 % ascorbic acid) was added to 50 µL of whole blood for the RBC folate analysis (Roche Diagnostics, Germany). Immunochemical analysis was performed using the chemiluminescent emission (analyser cobas e 411). It was based on a competitive test using the natural folate-binding protein specific for folate. Folate competes with the added folate for the binding sites of folate-binding protein labelled with ruthenium complex.
Statistical analyses were based on frequency analysis calculated at 97% accuracy with confidence limits for proportion. Analysis of median values for RBC folate concentration levels according to the mothers' questionnaire was done according to the Mann-Whitney or Kruskal-Wallis tests. The relationship between the micronutrient concentrations and different types of vitamin products was assessed by Kendall rank correlation coefficient. Differences were regarded as statistically significant at p < 0.05. Analyses were performed by Statsdirect version 2.8.0., Microsoft Office 2013.
Simple questionnaire for mothers of the observed children (Fig. S1 ) contained information about the types of foods eaten during pregnancy (healthy diet, vegetarian diet or some selected types of food which were refused) and the intake of folic acid or other multivitamin supplements containing also folic acid. The questionnaires were carried out face to face with the mothers of the newborns before the birth. Informed consent was obtained for every enrolled newborn's mother. The study was approved by the Ethics Committee of the Children's University Hospital in Bratislava 
Results
The study group included 150 healthy term newborns. The RBC folate levels ranged from 625 to 1748 ng/mL (5 th -95 th percentile). The median was 1062.5 ng/mL (Table 1) . Folate deficiency (< 140 ng/mL) was not observed in any sample.
Selected questions regarding the daily intake of folic acid during pregnancy were part of the questionnaire: (i) group A -1 mg folic acid (n = 45) and group B -multivitamin products containing minimum of 0.4 mg folic acid (n = 105) (Fig. 1) ; and (ii) types of foodhealthy diet, vegetarian diet or some selected types of food which were refused (Fig. 2) .
RBC folate concentration levels in newborns due to the mother's intake of multivitamin supplements were significantly increased (p = 0.02; Fig. 3 ) in comparison with the use of 1 mg of folic acid orally during the whole pregnancy. In the whole group of mothers a healthy diet was preferred. Only two mothers prioritized vegetarian diet. Three mothers did not eat selected types of food due to previous allergic reactions. No differences between the types of diet and the RBC folate concentrations in newborns levels were observed.
Discussion
Folate availability is important in some metabolic processes in the human body especially during the em-bryogenesis (Bjelakovic et al. 2012) . The benefit of folic acid in prevention of abnormal development was documented repeatedly in animal models (Ujházy et al. 2014) . The benefits of the use of folic acid in many branches of medicine are already known.
The determination of RBC folate concentration levels is the most accurate indicator of long-term folate level status in the body. The plasma folate concentration reflects accurate levels of folate in circulation but the RBC folate concentration is an indicator of longterm status. Because folate is taken up only by the developing erythrocyte in the bone marrow and not by the circulating mature erythrocyte during its 120-day lifespan, erythrocyte folate concentration is an indicator of long-term status (Institute of Medicine, Food and Nutrition Board 1998). Plasma folate concentration levels were found to decrease markedly with age (van Beynum et al. 2005) . It was observed in breastfed infants independent of maternal folate status that concentration levels of folate decrease from birth until 24 months (Hay et al. 2008 ). The normal RBC folate level in children is 150-600 ng/mL (Glader 2007) . Jyothi et al. (2007) published similar results for the levels of RBC folate concentration (486-724 ng/mL) and no deficiency (< 140ng/ mL) in the United-Kingdom-based study. In our results, folate deficiency was not observed in any sample compared with Jyothi et al. (2007) . The normal range of folate values vary due to the different analytical methods used to assess the RBC folate concentrations (Jackson 2006) . In our group of healthy full-term newborns we determined that the RBC folate concentration levels in umbilical cord samples reached 625-1748 ng/mL. We listed other factors which influenced these results. In one of them, we confirmed significantly higher RBC folate concentration levels in newborns due to the mother's multivitamin supplements intake shortly before the birth. Other factors also impacted the RBC levels, such as climate, race (Zhu & Ling 2008) or smoking habits (Bjørke-Monsen et al. 2004) . Folic acid fortification programs in some countries can influence the folate status in population (Gupta & Gupta 2004) .
The importance to determine the real RBC folate concentration levels is necessary for establishing the optimal folate intake in the nutrition of newborns, especially premature newborns. The impact of folate intake in neonatal period is due to the folate intake during pregnancy. It is necessary to distinguish the supplementation before conception and during the whole pregnancy or only during the third trimester of pregnancy. This reflects many studies that confirm the benefit of folic acid supplementation during pregnancy in decreasing the risk of NTD (Gupta & Gupta 2004; van der Linden et al. 2006; Behunova et al. 2010; Banhidy et al. 2011) . NTD including spina bifida, anencephaly and encephalocele are common serious birth defects and important causes of infant mortality and disability (van der Linden et al. 2006) . The distribution of NTD shows considerable geographical, temporal and ethnic variation (Zhu & Ling 2008; Banhidy et al. 2011; Deb et al. 2011; Hoyo et al. 2011) . Also, it is associated with genetic defects in the folate metabolism or as a consequence of dietary deficiency (Deb et al. 2011) . The folic acid supplementation during pregnancy varies worldwide. Recommended supplementation in Switzerland is initially at least four weeks before conception continuing until the end of the first trimester (Poretti et al. 2008) . Daily intake of 400 µg of folic acid during pregnancy is recommended for the reduction of structural birth defects and oro-facial clefts (Canfield et al. 2005; Wilcox et al. 2007 ). The Nordic countries set the reference intake 500 µg daily during pregnancy (Becker et al. 2004 ). The German-speaking countries assumed that the additional folate requirement of the foetus is 200 µg/day and recommended nutrient intake for a pregnant woman is 550 µg/day (D-A-CH 2013). In Slovakia the recommended daily intake is 400 µg of folic acid during pregnancy (Kajaba et al. 1997 ). In our study we confirmed the excellent awareness the newborns' mothers. All of them use some products with the minimum recommended dose of folic acid (minimally 400 µg of folic acid, but as a part of multivitamin supplements). We presume that an interaction of other substances in complicated metabolism pathways has taken place, which might have led to increased RBC folate concentration levels.
Folic acid supplementation decreases the incidence of NTD. The incidence of NTD in Slovakia is 0.53/1000 and the incidence among live born newborns is 0.28/1000 (Behunova et al. 2010) . However, the periconceptual recommendations of folic acid intake have not significantly decreased the birth prevalence of NTD in Switzerland (Poretti et al. 2008) . More than 95% cases with NTD are contributed to the first affected pregnancies. NTD recurrence risk in the United States is approximately 3%. Folic acid supplementation around the time of conception can decrease this risk by 85-100%. It is not clear how much supplements must be taken and how long prior to neural tube closure early in embryogenesis. A prophylactic dose of 0.3 mg per day had been recommended by the World Health Organization (WHO 2012) since 1968. Some researchers recommend that a high dose (4 mg/day) of folic acid taken around the time of conception prevents most recurrences of NTD (Grosse & Collins 2007) . Currently, the supplemental dose is recommended at 0.4 mg of folic acid daily (WHO 2012) . Use of folic acid in diabetic pregnant women has contributed to the diminished risk of congenital anomalies in pregnant women with diabetes mellitus (Banhidy et al. 2011) . Also, a daily intake of folic acid during pregnancy could have a positive impact on the bone turnover markers in mothers and their newborns (Hossein-nezhad et al. 2011) .
In some countries of the world the intake of folic acid is guaranteed through fortification of some products, such as flour. Folic acid fortification program proposed recommendations helped to eliminate NTD in some developing countries, but it is an important task and requires inter-sectoral co-operation (Gupta & Gupta 2004 ). Effect of folate supplementation can be determined via the concentration of malondialdehyde as an oxidative stress indicator in human milk. After folate supplementation, the significant malondialdehyde decrease was observed in colostrum and mature human milk (Bjelakovic et al. 2012) . In some countries such as Ireland it was reported that non-metabolized folic acid after fortification and the consequences of this are still unknown (Sweeney et al. 2009 ).
The analysis of its concentration in erythrocytes is the accurate indicator of body saturation by folic acid. In contrast to folic acid levels in serum, which reflect daily changes in the body and the impact of diet, the concentration of folates in erythrocytes is a reflection of a long-term process and their reserves in the body.
RBC folate concentration is influenced by several factors on both the mother's and the newborn's sides, and/or other associated complications. Our study provides data from the Slovak Republic and the actual state of RBC folate concentration levels from umbilical cord blood in term newborns on the first day of life, without further burdening of the newborn with repeated blood sampling. There are other factors affecting different folate levels after birth. To know the real RBC folate concentration levels in newborns on the first day of life may not only confirm the optimal folate intake during pregnancy, but it can also confirm the current background concentration in a newborn. It can thus affect the size of supplementation dose of folate in premature newborns, if necessary. We confirmed the influence of the maternal multivitamin supplements during pregnancy have on RBC folate concentration levels in the umbilical cord blood of their newborns. More studies are necessary to ascertain other factors affecting different folate levels in the perinatal period.
